Manufacturing recombinant adeno-associated viral vectors from producer cell clones.
about
Manufacturing of recombinant adeno-associated viral vectors for clinical trialsScalable downstream strategies for purification of recombinant adeno- associated virus vectors in light of the properties.Dab2 attenuates brain injury in APP/PS1 mice via targeting transforming growth factor-beta/SMAD signaling.Recombinant adeno-associated viral vector production and purification.Progress and challenges in viral vector manufacturingAdvanced Characterization of DNA Molecules in rAAV Vector Preparations by Single-stranded Virus Next-generation Sequencing.Widespread AAV1- and AAV2-mediated transgene expression in the nonhuman primate brain: implications for Huntington's disease.Manufacturing of recombinant adeno-associated viral vectors: new technologies are welcomeCharacteristics of Minimally Oversized Adeno-Associated Virus Vectors Encoding Human Factor VIII Generated Using Producer Cell Lines and Triple Transfection.Adeno-Associated Virus Gene Therapy for Liver Disease.MR-guided parenchymal delivery of adeno-associated viral vector serotype 5 in non-human primate brain.Manufacturing of recombinant adeno-associated viruses using mammalian expression platforms.Analysis of particle content of recombinant adeno-associated virus serotype 8 vectors by ion-exchange chromatography.Adeno-Associated Virus (AAV) as a Vector for Gene Therapy.Clearance and characterization of residual HSV DNA in recombinant adeno-associated virus produced by an HSV complementation system.Advancements in the design and scalable production of viral gene transfer vectors.Universal Method for the Purification of Recombinant AAV Vectors of Differing Serotypes.Pharmacology of Recombinant Adeno-associated Virus Production.
P2860
Q26750799-C414A593-C3A6-42DA-95A3-BE495995E948Q33555259-BF0DFBEA-7BF9-49C3-8EFF-4367A31512ACQ34096401-B7E8BDE4-392B-4515-A694-AFBCE1E7C11BQ35819157-64D46B6B-1222-4C7B-8838-C944411F107AQ36713761-5B266172-2AC4-40AC-8B45-2B0F319796FBQ36939744-F5D67950-A243-4503-99AA-BB333BE69244Q37051728-1A355977-D549-4CCE-AB0F-70F2B5AC7A6EQ38505122-577BBFB0-0F6B-404F-BAAE-FC71552683C8Q38717682-E4B58D0F-20F2-4408-88C3-5345A707A181Q38789554-F955A2C9-7679-4EB4-8E06-3E3316A25C54Q38903989-B27472FB-DC0B-4A47-805C-818CAD79639BQ39126013-66324DAA-B02C-4372-BAC3-CD0D402F049EQ39407680-20E78204-2ACF-4959-9122-ECAF41DA0D46Q39409371-3F35A488-5662-4CC0-B9C5-19D1B0F24A56Q39674124-368F0380-3DF7-4E34-9C23-55C2A89775E5Q41931475-A086CFD0-262D-4F19-8018-0B911071CFCCQ47551574-1BB37539-AD70-4F0A-ADB2-4A2CCAE92131Q52717185-C44F9039-81AB-4325-B8F7-C8FA45CA1B8A
P2860
Manufacturing recombinant adeno-associated viral vectors from producer cell clones.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Manufacturing recombinant adeno-associated viral vectors from producer cell clones.
@en
Manufacturing recombinant adeno-associated viral vectors from producer cell clones.
@nl
type
label
Manufacturing recombinant adeno-associated viral vectors from producer cell clones.
@en
Manufacturing recombinant adeno-associated viral vectors from producer cell clones.
@nl
prefLabel
Manufacturing recombinant adeno-associated viral vectors from producer cell clones.
@en
Manufacturing recombinant adeno-associated viral vectors from producer cell clones.
@nl
P2093
P356
P1433
P1476
Manufacturing recombinant adeno-associated viral vectors from producer cell clones.
@en
P2093
Barbara A Thorne
Richard W Peluso
Ryan K Takeya
P304
P356
10.1089/HUM.2009.070
P577
2009-07-01T00:00:00Z